Download
s12992-020-00637-5.pdf 564,96KB
WeightNameValue
1000 Titel
  • Promoting rational antibiotic use in Turkey and among Turkish migrants in Europe – implications of a qualitative study in four countries
1000 Autor/in
  1. Westerling, R. |
  2. Daryani, A. |
  3. Gershuni, O. |
  4. Czabanowska, K. |
  5. Brand, H. |
  6. Erdsiek, F. |
  7. Aksakal, T. |
  8. Uner, S. |
  9. Karadag Caman, O. |
  10. Ozcebe, H. |
  11. Brzoska, Patrick |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-11-11
1000 Erschienen in
1000 Quellenangabe
  • 16(1):108
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12992-020-00637-5 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656668/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Antimicrobial resistance is considered one of the major threats to global health. The emergence of resistant microorganisms is a consequence of irrational use of antibiotics. In Turkey, the consumption of antibiotics is relatively high and antibiotics are among the most commonly used drugs. However, Turkey has adopted new, more restrictive policies and regulations on antibiotics. In addition, Turkish migrants to EU countries, such as Germany, the Netherlands and Sweden, may encounter health systems that promote a more restrictive and rational antibiotic use. The objective of this paper was to explore the variation in implemented policies related to rational antibiotic use that citizens in Turkey and Turkish migrants in Germany, the Netherlands and Sweden are subjected to and to discuss the implications for the promotion of rational antibiotic use. Data were collected through focus groups and individual interviews with citizens, physicians and pharmacists in the four countries. In total, 130 respondents were interviewed. Content analysis was used.!##!Results!#!Three relevant themes were identified: Implementation of regulations and recommendations, Access to antibiotics and Need for health communication. Irrational use of antibiotics was reported mainly in Turkey. While it had become less likely to get antibiotics without a prescription, non-prescribed antibiotics remained a problem in Turkey. In the three EU countries, there were also alternative ways of getting antibiotics. Low levels of knowledge about the rational antibiotic use were reported in Turkey, while there were several sources of information on this in the EU countries. Communication with and trust in physicians were considered to be important. There were also system barriers, such as lacking opportunities for physicians to manage care in accordance with current evidence in Turkey and factors limiting access to care in EU countries.!##!Conclusions!#!Several fields of importance for promoting rational antibiotic use were identified. There is a need for harmonisation of health-related regulations and policy programmes. Antibiotics should only be available with a prescription. Programmes for rational antibiotic use should be implemented on a broad scale, in medical care, at pharmacies and in the population. Methods for health communication and patient-centred care should be further developed and implemented in this field.
1000 Sacherschließung
lokal Health system
lokal Pharmacists [MeSH]
lokal Quality of care
lokal Europe [MeSH]
lokal Health Promotion [MeSH]
lokal Anti-Bacterial Agents/therapeutic use [MeSH]
lokal Antimicrobial resistance
lokal Humans [MeSH]
lokal Turkey [MeSH]
lokal Germany
lokal Communication [MeSH]
lokal Migrants
lokal Health Knowledge, Attitudes, Practice [MeSH]
lokal Health policy
lokal The Netherlands
lokal Research
lokal Sweden
lokal Antibiotics
lokal Turkey
lokal Focus Groups [MeSH]
lokal Migration and mobilities
lokal Transients and Migrants [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/V2VzdGVybGluZywgUi4=|https://frl.publisso.de/adhoc/uri/RGFyeWFuaSwgQS4=|https://frl.publisso.de/adhoc/uri/R2Vyc2h1bmksIE8u|https://frl.publisso.de/adhoc/uri/Q3phYmFub3dza2EsIEsu|https://frl.publisso.de/adhoc/uri/QnJhbmQsIEgu|https://frl.publisso.de/adhoc/uri/RXJkc2llaywgRi4=|https://frl.publisso.de/adhoc/uri/QWtzYWthbCwgVC4=|https://frl.publisso.de/adhoc/uri/VW5lciwgUy4=|https://frl.publisso.de/adhoc/uri/S2FyYWRhZyBDYW1hbiwgTy4=|https://frl.publisso.de/adhoc/uri/T3pjZWJlLCBILg==|https://orcid.org/0000-0001-6489-5198
1000 Hinweis
  • DeepGreen-ID: d3e3ffbf4ba948a790a9256eddf034ff ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6452494.rdf
1000 Erstellt am 2023-05-12T15:26:47.280+0200
1000 Erstellt von 322
1000 beschreibt frl:6452494
1000 Zuletzt bearbeitet Tue Oct 24 08:10:21 CEST 2023
1000 Objekt bearb. Tue Oct 24 08:10:21 CEST 2023
1000 Vgl. frl:6452494
1000 Oai Id
  1. oai:frl.publisso.de:frl:6452494 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source